The Lancet Microbe · 2024 · 18 citations · 6 references
Life SciencesInfectious DiseasesMicrobiologyAntimicrobial PharmacotherapyImmunizationMedical MicrobiologyAntibiotic ResistanceAntimicrobial Resistance ControlAntimicrobial Resistance PreventionBacterial EpidemiologyBacterial InfectionsTargeted Antimicrobial TherapyAntibiotic Resistance PreventionAntibiotic-resistant Pathogen ControlDrug Resistance PatternsShigella Resistance
Shigellosis, caused by bacteria of the genus Shigella, is a diarrhoeal disease transmitted by the faecal–oral route.1 Rapid increases in the prevalence of extensively drug-resistant (XDR) Shigella isolates—also known as triple-resistant due to resistance to fluoroquinolones, third-generation cephalosporins, and azithromycin—during the final quarter of 2021 and the first quarter of 2022 in Europe, Northern America, and Australia have highlighted the urgent need to develop new antimicrobials and vaccines targeting high-priority Shigella spp.
6
V L Gilbart, Ian Simms, Claire Jenkins et al. · Sexually Transmitted Infections · 2015 · 171 citations · Full text
Medicine, Infectious Disease Control, Preventive Medicine +14
Hannah Charles, Mateo Prochazka, Katie Thorley et al. · The Lancet Infectious Diseases · 2022 · 108 citations · Full text
Veterinary Medicine, Infectious Disease Control, Infectious Diseases +14
Daniel Richardson, Mark Pakianathan, Michael Ewens et al. · International Journal of STD & AIDS · 2023 · 44 citations · Full text
Veterinary Medicine, Infectious Disease Control, Infectious Diseases +17